BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berghmans T, Lievens Y, Aapro M, Baird AM, Beishon M, Calabrese F, Dégi C, Delgado Bolton RC, Gaga M, Lövey J, Luciani A, Pereira P, Prosch H, Saar M, Shackcloth M, Tabak-Houwaard G, Costa A, Poortmans P. European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer. Lung Cancer 2020;150:221-39. [PMID: 33227525 DOI: 10.1016/j.lungcan.2020.08.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Xi C, Jiang H, Xue Y, Lv Y, Wang C, Asghar M. Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/9422902] [Reference Citation Analysis]
2 Fang R, Liao H, Mardani A. How to aggregate uncertain and incomplete cognitive evaluation information in lung cancer treatment plan selection? A method based on Dempster-Shafer theory. Information Sciences 2022;603:222-43. [DOI: 10.1016/j.ins.2022.04.060] [Reference Citation Analysis]
3 Huang L, Feng C. Effect of Refined Perioperative Nursing on the Efficacy of Noninvasive Ventilation in Elderly Patients with Lung Cancer and Respiratory Failure. J Oncol 2022;2022:4711935. [PMID: 35756083 DOI: 10.1155/2022/4711935] [Reference Citation Analysis]
4 Mangiameli G, Cioffi U, Testori A. Lung Cancer Treatment: From Tradition to Innovation. Front Oncol 2022;12:858242. [DOI: 10.3389/fonc.2022.858242] [Reference Citation Analysis]
5 Vaz SC, Adam JA, Bolton RCD, Vera P, van Elmpt W, Herrmann K, Hicks RJ, Lievens Y, Santos A, Schöder H, Dubray B, Visvikis D, Troost EGC, de Geus-Oei LF. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. Eur J Nucl Med Mol Imaging 2022. [PMID: 35022844 DOI: 10.1007/s00259-021-05624-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Vaz SC, Adam JA, Delgado Bolton RC, Vera P, van Elmpt W, Herrmann K, Hicks RJ, Lievens Y, Santos A, Schöder H, Dubray B, Visvikis D, Troost EG, de Geus-oei L. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer. Radiotherapy and Oncology 2022. [DOI: 10.1016/j.radonc.2021.12.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Guirado M, Sanchez-Hernandez A, Pijuan L, Teixido C, Gómez-Caamaño A, Cilleruelo-Ramos Á. Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group. Clin Transl Oncol 2021. [PMID: 34665437 DOI: 10.1007/s12094-021-02712-8] [Reference Citation Analysis]
8 Sundahl N, Lievens Y. Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review. Transl Lung Cancer Res 2021;10:3420-31. [PMID: 34430377 DOI: 10.21037/tlcr-20-1051] [Reference Citation Analysis]
9 Goussault H, Gendarme S, Assié JB, Bylicki O, Chouaïd C. Factors associated with early lung cancer mortality: a systematic review. Expert Rev Anticancer Ther 2021;:1-9. [PMID: 34121578 DOI: 10.1080/14737140.2021.1941888] [Reference Citation Analysis]
10 Lawler M, Oliver K, Gijssels S, Aapro M, Abolina A, Albreht T, Erdem S, Geissler J, Jassem J, Karjalainen S, La Vecchia C, Lievens Y, Meunier F, Morrissey M, Naredi P, Oberst S, Poortmans P, Price R, Sullivan R, Velikova G, Vrdoljak E, Wilking N, Yared W, Selby P. The European Code of Cancer Practice. Journal of Cancer Policy 2021;28:100282. [DOI: 10.1016/j.jcpo.2021.100282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Popat S, Navani N, Kerr KM, Smit EF, Batchelor TJP, Van Schil P, Senan S, McDonald F. Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach. Oncologist 2021;26:e306-15. [PMID: 33145902 DOI: 10.1002/onco.13586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]